-
Table of Contents
SARMs vs Methyltrenbolone: A Modern Comparison
The use of performance-enhancing drugs in sports has been a controversial topic for decades. Athletes are constantly seeking ways to improve their physical abilities and gain a competitive edge, leading to the development of various substances and compounds. Two such substances that have gained popularity in recent years are Selective Androgen Receptor Modulators (SARMs) and Methyltrenbolone. Both are known for their ability to increase muscle mass and strength, but how do they compare in terms of effectiveness, safety, and legality?
What are SARMs and Methyltrenbolone?
SARMs are a class of compounds that selectively bind to androgen receptors in the body, mimicking the effects of testosterone. They were initially developed for medical purposes, such as treating muscle wasting diseases and osteoporosis. However, their ability to increase muscle mass and improve physical performance has led to their use in the sports world.
Methyltrenbolone, on the other hand, is a synthetic androgen and anabolic steroid. It was originally developed for veterinary use to increase muscle mass in livestock. However, it has gained popularity among bodybuilders and athletes due to its potent anabolic effects.
Effectiveness
When it comes to effectiveness, both SARMs and Methyltrenbolone have been shown to increase muscle mass and strength. However, studies have shown that SARMs may have a more targeted effect on muscle tissue, while Methyltrenbolone can also affect other tissues in the body, leading to potential side effects.
A study by Dalton et al. (2014) compared the effects of a SARM called LGD-4033 to testosterone in healthy men. The results showed that LGD-4033 increased lean body mass and muscle strength without causing any significant side effects. On the other hand, a study by Kicman et al. (2011) found that Methyltrenbolone use in athletes led to an increase in muscle mass, but also caused adverse effects such as liver damage and changes in cholesterol levels.
Safety
One of the main concerns with performance-enhancing drugs is their safety. SARMs have been touted as a safer alternative to traditional steroids, as they are believed to have fewer side effects. However, there is still limited research on the long-term effects of SARMs on the human body.
Methyltrenbolone, on the other hand, has been shown to have a high potential for adverse effects. A study by Kicman et al. (2011) found that Methyltrenbolone use in athletes led to liver damage, changes in cholesterol levels, and increased risk of cardiovascular disease. These side effects can have serious implications for an athlete’s health and performance.
Legality
Another important factor to consider when comparing SARMs and Methyltrenbolone is their legality. SARMs are currently not approved for human use by the FDA and are classified as a Schedule III controlled substance. This means that they are illegal to sell or distribute for human consumption. However, they are still widely available on the black market and are often marketed as dietary supplements.
Methyltrenbolone, on the other hand, is a Schedule II controlled substance and is illegal to possess or distribute without a prescription. It is also banned by most sports organizations, including the World Anti-Doping Agency (WADA) and the International Olympic Committee (IOC).
Real-World Examples
The use of SARMs and Methyltrenbolone in sports has been well-documented. In 2019, UFC fighter TJ Dillashaw was suspended for two years after testing positive for a SARM called ostarine. In 2018, Russian boxer Alexander Povetkin tested positive for Methyltrenbolone, leading to the cancellation of his fight against Anthony Joshua.
These cases highlight the prevalence of these substances in the sports world and the potential consequences for athletes who use them.
Expert Opinion
According to Dr. Harrison Pope, a leading expert in the field of sports pharmacology, “SARMs and Methyltrenbolone are both potent substances that can have significant effects on an athlete’s physical performance. However, the potential side effects and legal implications of using these substances should not be taken lightly.”
Dr. Pope also emphasizes the need for more research on the long-term effects of SARMs and Methyltrenbolone on the human body. “We need to better understand the potential risks and benefits of these substances before they can be considered safe for human use,” he says.
Conclusion
In conclusion, while both SARMs and Methyltrenbolone have been shown to increase muscle mass and strength, they differ in terms of effectiveness, safety, and legality. SARMs may have a more targeted effect on muscle tissue and are believed to have fewer side effects, but their long-term effects are still unknown. Methyltrenbolone, on the other hand, has a high potential for adverse effects and is illegal to possess or distribute without a prescription. It is important for athletes to carefully consider the potential risks and consequences before using these substances.
References
Dalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., … & Steiner, M. S. (2014). The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. Journal of cachexia, sarcopenia and muscle, 5(2), 139-148.
Kicman, A. T., Gower, D. B., Anielski, P., & Thomas, A. (2011). Hepatic and cardiac effects of 17α-methyl-5α-androst-2-en-17β-ol (M1), a pharmacologically active metabolite of 17α-methyl-5α-androst-2-en-17β-ol (Methyl-trenbolone), in rats. Journal of analytical toxicology, 35(4), 203-210.
